leflunomide 20mg tablets
a a h pharmaceuticals ltd - leflunomide - tablet - 20mg
leflunomide 20mg tablets
teva uk ltd - leflunomide - tablet - 20mg
leflunomide 20mg tablets
actavis uk ltd - leflunomide - tablet - 20mg
leflunomide 20mg tablets
waymade healthcare plc - leflunomide - tablet - 20mg
leflunomide 20mg tablets
morningside healthcare ltd - leflunomide - tablet - 20mg
leflunomide 20mg tablets
sigma pharmaceuticals plc - leflunomide - tablet - 20mg
leflunomide ch leflunomide 100mg tablet blister pack
southern cross pharma pty ltd - leflunomide, quantity: 100 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - treatment of active rheumatoid arthritis. the combined use of leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).
leflunomide ch leflunomide 10mg tablet bottle
southern cross pharma pty ltd - leflunomide, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; povidone; crospovidone; magnesium stearate; lactose monohydrate; maize starch; titanium dioxide; hypromellose; macrogol 4000 - treatment of active rheumatoid arthritis. the combined use of leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).
leflunomide sz leflunomide 100mg tablet blister pack
southern cross pharma pty ltd - leflunomide, quantity: 100 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - treatment of active rheumatoid arthritis. the combined use of leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).
leflunomide tablet
remedyrepack inc. - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide tablets are indicated for the treatment of adults with active rheumatoid arthritis (ra). leflunomide tablets are contraindicated in: - pregnant women. leflunomide tablets may cause fetal harm. if a woman becomes pregnant while taking this drug, stop leflunomide tablets, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure [ see warnings and precautions (5.1 and 5.3) and use in specific populations (8.1 )]. patients with severe hepatic impairment [ see warnings and precautions (5.2) ]. - patients with known hypersensitivity to leflunomide or any of the other components of leflunomide tablets. known reactions include anaphylaxis [ see adverse reactions (6.1) ]. - patients being treated with teriflunomide [ see drug interactions (7) ]. risk summary leflunomide tablets are contraindicated for use in pregnant women because of the potential for fetal harm. in animal reproduction studies, oral administ